FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1217206004: Tenofovir disoproxil maleate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5035125019 Tenofovir disoproxil maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5035126018 Tenofovir disoproxil maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tenofovir disoproxil maleate Is a Reverse transcriptase inhibitor true Inferred relationship Some
Tenofovir disoproxil maleate Is a Carboxylic ester (substance) true Inferred relationship Some
Tenofovir disoproxil maleate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Reverse transcriptase inhibitor (disposition) true Inferred relationship Some
Tenofovir disoproxil maleate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tenofovir disoproxil (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir disoproxil maleate Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir disoproxil maleate Inferred relationship Some 3
Tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir disoproxil maleate Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start